Sarah Alfaqaih
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sarah Alfaqaih has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Nawara Ghlio
Department of Pediatric Oncology, National Cancer Institute, Misurata, Libya
2 shared publications A. Khashan
Raritan Bay Medical Center, Perth Amboy, NJ, USA
1 shared publicationA.K. Wali
Faculty of Medicine, University of Tripoli, Libya
1 shared publicationE. Basheer
Faculty of Medicine, Sebha University, Sabha, Libya
1 shared publicationE.T. Hassan
Tripoli University Hospital, Tripoli, Libya
1 shared publication- Ebtesam Salem
Department of Pediatrics, Faculty of Medicine, University of Misurata, Misurata, Libya; Pediatric Intensive Care Unit, Misurata Medical Center, Misurata, Libya
1 shared publication
Latest Publications
- Open Access
- 1 October 2026
- Published by Attahadi Medical University in Libyan Medical Journal
- p. 673-680
Diabetic Ketoacidosis with Severe Dyslipidemia in a Pediatric Patient with New-Onset Type 1 Diabetes Mellitus: A Case Report
Diabetic ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus (T1DM). Although mild hypertriglyceridemia (HTG) is common in DKA, severe HTG (triglycerides >2000 mg/dL) is rare in pediatric patients and markedly increases the risk of acute pancreatitis (AP). This report describes a unique case of new-onset T1DM presenting with DKA and extreme dyslipidemia, highlighting management challenges. An 11-year-old girl presented with fatigue, dehydration, and Kussmaul breathing. Laboratory tests confirmed DKA (pH 7.01, blood glucose 490 mg/dL) and showed a severely lipemic blood sample. Initial management included fluid resuscitation and an intravenous insulin infusion. Although DKA resolved within 48 hours, triglyceride (TG) levels surged from 1271 to 3967 mg/dL on the fourth day after reducing the intravenous insulin infusion rate from 0.1 to 0.05 IU/kg/h, accompanied by mild abdominal pain. AP was ruled out by ultrasound, and enzyme levels were normal. Management required readjusting the insulin infusion rate and initiating oral lipid-lowering agents (fenofibrate, rosuvastatin, and omega-3). TG levels normalized within 20 days, though low-density lipoprotein (LDL) remained elevated, consistent with the beta shift phenomenon. A significant family history of hyperlipidemia suggested a genetic predisposition. Severe HTG is a critical complication of pediatric DKA that requires prompt recognition and treatment. Intravenous insulin remains the primary treatment, but clinicians must monitor for rebound lipid levels after acidosis resolves. Oral lipid-lowering therapies are effective adjuncts, especially when plasmapheresis is unavailable. This case emphasizes the need for individualized management and long-term lipid monitoring in pediatric T1DM.
- 1 October 2026
- Published by Attahadi Medical University in Libyan Medical Journal
- p. 673-680
Open AccessDiabetic Ketoacidosis with Severe Dyslipidemia in a Pediatric Patient with New-Onset Type 1 Diabetes Mellitus: A Case Report
Diabetic ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus (T1DM). Although mild hypertriglyceridemia (HTG) is common in DKA, severe HTG (triglycerides >2000 mg/dL) is rare in pediatric patients and markedly increases the risk of acute pancreatitis (AP). This report describes a unique case of new-onset T1DM presenting with DKA and extreme dyslipidemia, highlighting management challenges. An 11-year-old girl presented with fatigue, dehydration, and Kussmaul breathing. Laboratory tests confirmed DKA (pH 7.01, blood glucose 490 mg/dL) and showed a severely lipemic blood sample. Initial management included fluid resuscitation and an intravenous insulin infusion. Although DKA resolved within 48 hours, triglyceride (TG) levels surged from 1271 to 3967 mg/dL on the fourth day after reducing the intravenous insulin infusion rate from 0.1 to 0.05 IU/kg/h, accompanied by mild abdominal pain. AP was ruled out by ultrasound, and enzyme levels were normal. Management required readjusting the insulin infusion rate and initiating oral lipid-lowering agents (fenofibrate, rosuvastatin, and omega-3). TG levels normalized within 20 days, though low-density lipoprotein (LDL) remained elevated, consistent with the beta shift phenomenon. A significant family history of hyperlipidemia suggested a genetic predisposition. Severe HTG is a critical complication of pediatric DKA that requires prompt recognition and treatment. Intravenous insulin remains the primary treatment, but clinicians must monitor for rebound lipid levels after acidosis resolves. Oral lipid-lowering therapies are effective adjuncts, especially when plasmapheresis is unavailable. This case emphasizes the need for individualized management and long-term lipid monitoring in pediatric T1DM.
- Open Access
- 6 July 2026
- Published by Misurata University in Misurata Medical Sciences Journal
- Vol. 8 (2) , 1-6
Familial Hemophagocytic Lymphohistiocytosis Type 3 - UNC13D mutation: A rare case report with comprehensive management and outcome
Background: Familial hemophagocytic lymphohistocytosis (FHL) is a rare autosomal recessive disease, resulting in an often-fatal presentation with persistent pyrexia, splenomegaly and cytopenia. The familial type of hemophagocytic lymphohistiocytosis is caused by mutations in several genes, including PRF1, STX11, STXBP2, Munc13-4, HPLH1, and UNC13D. We aimed to identify the genetically confirmed case of FHL and the pattern of presentation and outcome. Case presentation: We report a 4-month-old female patient who presented with typical signs and symptoms that fulfil HLH-2004 criteria. The UNC13D gene by whole exome sequences confirms a homozygous likely variant detected "c. 1828_1839del p(Arg610_Gln613del)". The HLH-2004 protocol was administered with excellent response. As a reason for delayed allogeneic hematopoietic stem cell transplantation (HSCT) after the protocol completion of 52 weeks, the patient has disease reactivation, which required re-induction of the protocol that ended successfully with HSCT. Conclusions: Our case aimed for a multifaceted presentation and clinical pattern in FHLH; remission can be achieved with immunosuppressive therapy and chemotherapy, but allo-HSCT is required for cure.
- 6 July 2026
- Published by Misurata University in Misurata Medical Sciences Journal
- Vol. 8 (2) , 1-6
Open AccessFamilial Hemophagocytic Lymphohistiocytosis Type 3 - UNC13D mutation: A rare case report with comprehensive management and outcome
Background: Familial hemophagocytic lymphohistocytosis (FHL) is a rare autosomal recessive disease, resulting in an often-fatal presentation with persistent pyrexia, splenomegaly and cytopenia. The familial type of hemophagocytic lymphohistiocytosis is caused by mutations in several genes, including PRF1, STX11, STXBP2, Munc13-4, HPLH1, and UNC13D. We aimed to identify the genetically confirmed case of FHL and the pattern of presentation and outcome. Case presentation: We report a 4-month-old female patient who presented with typical signs and symptoms that fulfil HLH-2004 criteria. The UNC13D gene by whole exome sequences confirms a homozygous likely variant detected "c. 1828_1839del p(Arg610_Gln613del)". The HLH-2004 protocol was administered with excellent response. As a reason for delayed allogeneic hematopoietic stem cell transplantation (HSCT) after the protocol completion of 52 weeks, the patient has disease reactivation, which required re-induction of the protocol that ended successfully with HSCT. Conclusions: Our case aimed for a multifaceted presentation and clinical pattern in FHLH; remission can be achieved with immunosuppressive therapy and chemotherapy, but allo-HSCT is required for cure.
- Open Access
- 29 December 2025
- Published by The University of Jordan in Jordan Medical Journal
- Vol. 59 (5)
A Three-Year Retrospective Analysis of the Common Isolated Microorganisms and the Sensitivity Pattern of Blood Culture in Children with Cancer
Background: Cancer patients receiving chemotherapy are facing a higher risk of bloodstream infection (BSI) because of febrile neutropenia. In febrile neutropenia, rational use of antibiotics is important for reducing morbidity and preventing the emergence of drug-resistant bacteria. There is a lack of data on BSI epidemiology in Libyan pediatric cancer patients. We conducted this study to determine the frequency and type of isolated microorganisms, as well as the profile of antibiotic resistance. Material and methods: This was a three-year retrospective study, 2021-2023. We recorded data on all blood cultures taken from pediatric cancer patients treated at the National Cancer Institute, Misurata, between January 2021 and December 2023. We analyzed the microbiological profile and sensitivity pattern. Results: The pediatric oncology department sent 615 blood culture samples (168 central venous catheters, 447 peripheral veins) to patients admitted with febrile neutropenia. There were 106/615 (17.6%) positive cultures. Gram-positive organisms were the most commonly isolated bacteria, accounting for 58.2%, and Gram-negative organisms accounted for 37.8%. Staphylococcus aureus 56.6% was the most common Gram-positive, and Pseudomonas areogenosa was the most common among Gram-negative bacterium (24/38, 63.15%), followed by Klebsiella pneumonia (13/38, 34.2%). A higher proportion of carbapenem resistance isolates were seen in Klebsiella pneumonia (10/13, 77%). Conclusion: The prompt detection of microbial isolates in cancer patients is fundamental to developing an appropriate early treatment policy. The emergence of antibiotic-resistant bacteria is alarming for the use of antibiotics and for institutional infection control protocols.
- 29 December 2025
- Published by The University of Jordan in Jordan Medical Journal
- Vol. 59 (5)
Open AccessA Three-Year Retrospective Analysis of the Common Isolated Microorganisms and the Sensitivity Pattern of Blood Culture in Children with Cancer
Background: Cancer patients receiving chemotherapy are facing a higher risk of bloodstream infection (BSI) because of febrile neutropenia. In febrile neutropenia, rational use of antibiotics is important for reducing morbidity and preventing the emergence of drug-resistant bacteria. There is a lack of data on BSI epidemiology in Libyan pediatric cancer patients. We conducted this study to determine the frequency and type of isolated microorganisms, as well as the profile of antibiotic resistance. Material and methods: This was a three-year retrospective study, 2021-2023. We recorded data on all blood cultures taken from pediatric cancer patients treated at the National Cancer Institute, Misurata, between January 2021 and December 2023. We analyzed the microbiological profile and sensitivity pattern. Results: The pediatric oncology department sent 615 blood culture samples (168 central venous catheters, 447 peripheral veins) to patients admitted with febrile neutropenia. There were 106/615 (17.6%) positive cultures. Gram-positive organisms were the most commonly isolated bacteria, accounting for 58.2%, and Gram-negative organisms accounted for 37.8%. Staphylococcus aureus 56.6% was the most common Gram-positive, and Pseudomonas areogenosa was the most common among Gram-negative bacterium (24/38, 63.15%), followed by Klebsiella pneumonia (13/38, 34.2%). A higher proportion of carbapenem resistance isolates were seen in Klebsiella pneumonia (10/13, 77%). Conclusion: The prompt detection of microbial isolates in cancer patients is fundamental to developing an appropriate early treatment policy. The emergence of antibiotic-resistant bacteria is alarming for the use of antibiotics and for institutional infection control protocols.
- Open Access
- 23 August 2025
- Published by Attahadi Medical University
- p. 239-246
Parental Stress and Childhood Cancer in Libya: A Cross-Sectional Study in Misurata
Children worldwide continue to be impacted by both chronic and acute diseases. Although there has been a huge improvement in survival rates in the last decades, the psychosocial impact of childhood cancer cannot be underestimated. This study aims to determine the prevalence of cancer-related stress among parents of children undergoing cancer treatment in Misurata, Libya. A cross-sectional survey by the Perceived Stress Scale 10-items (PSS-10) was conducted between March 21, 2023, and January 15, 2024, among the parents caring for children diagnosed with cancer, and parents who care for children without cancer. In this study, 597 respondents were included in the analysis: 364 mothers (61%), and 233 fathers (39%). The mean (SD) age of the respondents (587/597) was 38.12 (8.46). The stress symptoms, which were assessed using the PSS-10 scale, had a mean (SD) score of 17.58 (6.6), and the following categories were identified: low stress (0–13) 169 (28.3%); moderate stress (14–26) 368 (61.6%); and severe stress (27–40) 60 (10.1%). A statistically significant association was found between stress symptoms and the following variables: parents (χ2= 23.7, p <0.0001), age range (under or over 35 years old) (χ2= 19.49, p <0.0001), cancer status (χ2= 24.58, p =0.039), stage of treatment (χ2= 17.89, p =0.006), and distance from the primary hospital (χ2= 12.04, p =0.017). Our findings confirm a significant association between a child’s cancer diagnosis and parental stress, highlighting the differential impact of various child- and parent-related factors.
- 23 August 2025
- Published by Attahadi Medical University
- p. 239-246
Open AccessParental Stress and Childhood Cancer in Libya: A Cross-Sectional Study in Misurata
Children worldwide continue to be impacted by both chronic and acute diseases. Although there has been a huge improvement in survival rates in the last decades, the psychosocial impact of childhood cancer cannot be underestimated. This study aims to determine the prevalence of cancer-related stress among parents of children undergoing cancer treatment in Misurata, Libya. A cross-sectional survey by the Perceived Stress Scale 10-items (PSS-10) was conducted between March 21, 2023, and January 15, 2024, among the parents caring for children diagnosed with cancer, and parents who care for children without cancer. In this study, 597 respondents were included in the analysis: 364 mothers (61%), and 233 fathers (39%). The mean (SD) age of the respondents (587/597) was 38.12 (8.46). The stress symptoms, which were assessed using the PSS-10 scale, had a mean (SD) score of 17.58 (6.6), and the following categories were identified: low stress (0–13) 169 (28.3%); moderate stress (14–26) 368 (61.6%); and severe stress (27–40) 60 (10.1%). A statistically significant association was found between stress symptoms and the following variables: parents (χ2= 23.7, p <0.0001), age range (under or over 35 years old) (χ2= 19.49, p <0.0001), cancer status (χ2= 24.58, p =0.039), stage of treatment (χ2= 17.89, p =0.006), and distance from the primary hospital (χ2= 12.04, p =0.017). Our findings confirm a significant association between a child’s cancer diagnosis and parental stress, highlighting the differential impact of various child- and parent-related factors.